|Articles|February 14, 2019

Tackling Zika Transmission at the Source With Genetically Engineered Resistant Mosquitoes

As several Zika virus vaccine candidates undergo clinical trials, a group of investigators is taking an alternate approach to quell transmission by genetically engineering mosquitoes to be resistant to the virus.

As several Zika virus vaccine candidates undergo clinical trials, a group of investigators is taking an alternate approach to quell transmission by genetically engineering mosquitoes to be resistant to the virus.

In a new study published in the journal Proceedings of the National Academy of Sciences (PNAS), a team from the University of California, San Diego, collaborated with investigators in Australia and Taiwan and used genomic technology to generate a mosquito that is resistant to Zika virus.

“Transgenic-based (and specifically synthetic small RNA- based) methods for making disease-refractory mosquitoes can be quite effective,” Anna B. Buchman, PhD, research data analyst at Akbari Lab, Division of Biological Sciences, University of California, San Diego, and lead investigator on the study, told Contagion®.

“There have been previous efforts to use transgenes in general, and miRNAs in particular, to render mosquitoes refractory to several mosquito-borne diseases (although never ZIKV), however, many of them were not 100% effective,” she continued. “What we really saw with our study was that, with some optimization, it is really possible to make mosquitoes that are 100% resistant to a disease and still have high fitness.”

To do that, investigators took Aedes aegypti mosquitoes at the embryonic stage and injected them with an anti-Zika gene and another gene that expresses red eyes in order to tell the modified ones apart. The engineered mosquitoes displayed lower levels of viral infection, dissemination, and transmission.

“Our results demonstrate that engineered mosquitoes express a polycistronic cluster of synthetic small RNAs designed to target the ZIKV genome. As a result, homozygous mosquitoes were refractory to ZIKV infection, and therefore could not transmit the virus,” the investigators wrote.

This strategy of vector control could one day replace the wild populations of the Aedes aegypti mosquito, according to the investigators.

“Further investigation of this technology is needed before we could look at taking this beyond the lab. There are certain technologies available, like gene drive, which could be used to penetrate the wild population with these mosquitoes. This would require breeding a large number of these mosquitoes in a lab and releasing them in affected regions to stop transmission,” Prasad N. Paradkar, PhD, research scientist at CSIRO Health and Biosecurity, Australian Animal Health Laboratory, and co-author of the study, told Contagion®.

“However, we’re not at that stage yet,” Dr. Paradkar continued. “We need to conduct further experiments and risk analysis around the ecological safety of this work, and there would need to be well-informed public discussion and community engagement around this possible avenue, alongside with the necessary regulatory approvals.”

Dr. Buchman believes future research should focus on both vector control and alternative prevention measures.

“Ultimately, given the impact of these diseases, the mosquito is the deadliest animal in the world, and millions of people all over the world suffer because of the diseases this animal spreads,” she said. “Researchers and clinicians need to work together to develop multi-pronged approaches to try to control these diseases.”


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.
FAQ: XDR Shigella
Here is some important information around this pathogen and the intestinal infection.
The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.